| Trial ID: | L0965 |
| Source ID: | JPRN-UMIN000002641
|
| Associated Drug: |
Telmisartan
|
| Title: |
A open label, randomized, controled trial to assess the usefulness of telmisartan in patients with type 2 diabetes, obesity, and NAFLD
|
| Acronym: |
--
|
| Status: |
Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
type 2 diabetes mellitus
|
| Interventions: |
(Telmisartan group)<br>Patients under treatment with telmisartan (40mg/day) are switched from valsartan (80mg/day) to telmisartan at the dose of 40mg/day for 6months.<br>(Valsartan group)<br>Patients under treatment with valsartan (80mg/day) group will co
|
| Outcome Measures: |
Content of visceral fat and fatty liverHbA1c, fasting glucose, fasting CPR, ABI/PWV, body weight, blood pressure
|
| Sponsor/Collaborators: |
MATSUYAMA SHIMIN HOSPITAL
|
| Gender: |
All
|
| Age: |
20years-oldNot applicable
|
| Phases: |
Not applicable
|
| Enrollment: |
50
|
| Study Type: |
Interventional
|
| Study Designs: |
Parallel Randomized
|
| Start Date: |
21/10/2009
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
2 April 2019
|
| Locations: |
Japan
|
| URL: |
https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000003219
|
